Two Arrested In Tokyo For Selling ¥170 Million Worth Of Botox Without Permission
This article was originally published in PharmAsia News
Executive Summary
Tokyo based drug importer Forclinic President Kim Tae-hyon and another worker were arrested July 31 for violating the Pharmaceutical Affairs Law and selling drugs containing botulinum toxin without permission. Imported from Hong Kong, the drug has not been approved in Japan. According to the authority, the company sold it to 180 clinics nationwide and the sales totaled ¥170 million within a year. (Click here for more - Japanese language